Industry Insider: An Inside Look at OSNovative Systems, Inc.

For this month’s feature, Today’s Wound Clinic spoke with Oleg Siniaguine, PhD, president and CEO of OSNovative Systems Inc.

  Today’s Wound Clinic (TWC): How would you describe the overall mission of your company?
  Oleg Siniaguine (OS): Our mission is to help patients and clinicians by providing the right tools to achieve fast, painless healing of all wounds. We continue to strive to achieve our goal of improving the quality of patients’ lives, cutting provider and home care costs, and making the work of wound care professionals more rewarding.

  TWC: What do you find most rewarding about providing for your industry?
  OS: The feedback from patients and medical professionals. Hearing that we helped someone get their life back after dealing with a chronic wound, seeing how excited nurses are when they learn that better wound care is possible and does work – all this makes our entire team very proud of what we do.

  TWC: What’s new with your company in 2014?
  OS: It has been an exceptional year so far. OSNovative received the 2014 North American Frost & Sullivan Award for New Product Innovation Leadership.

  The award recognizes companies committed to groundbreaking innovation and those developing products that leverage leading-edge technologies. Our self-adaptive technology is the first truly significant development in decades that is likely to reform the wound care industry as we know it.

  TWC: What are your most popular products and/or services?
  OS: Our hands are full with producing ENLUXTRA self-adaptive wound dressing in three sizes: 2” x 2,” 4” x 4,” and 6” x 6.”

  ENLUXTRA is a “smart” dressing born as a technological response to clinicians’ dreams of a wound dressing that could automatically “decide” what to do – absorb exudate or hydrate a wound – and help to heal the wounds fast and with minimal pain, hassles, and costs.

  ENLUXTRA is made of medical-grade synthetic polymers including immobilized hydrogels and superabsorbent polymers. Our product is latex-free and has a microorganism and fluid strike-through barrier.

  The dressing reversibly controls moisture losses over the dry or low-exuding areas of the wound and facilitates intensive moisture evacuation over the excessively draining wound areas. The exudate and liquefied products of natural autolytic debridement are locked in the dressing, away from the wound bed and skin, preventing maceration and supporting granulation.

  Microorganisms are evacuated from the wound bed as well and sequestered by the bacteriostatic material, resulting in reduction of the wound bioburden and odor.

  We also continue to receive requests for other formats of the dressing and will be introducing additional self-adaptive products in the near future.

  In an era of smart gadgets and applications used everywhere, it is natural to start thinking about smart designs and materials for wound care. Having a background in medical devices and nano- and microtechnology, I’ve found that task interesting and challenging.

  TWC: How is your company approaching the challenges in wound care?
  OS: The modern wound care science states that to ensure an optimal healing environment, each particular wound tissue type has to be treated with a specifically purposed dressing.

  However, every real wound has several tissue types at any given moment and the drainage intensity may vary from none to very high within the same wound as well. So, the challenge for the ideal dressing is to provide contradictory functions at different areas of the wound, all at the same time.

  Wound care professionals face the problem of choosing the correct product for any given wound and deciding which product to switch to as the wound condition evolves. More often than not, these choices are driven by educated guesses or trial-and-error approaches.

  We took on this challenge and created a product that eliminates the guesswork, dramatically simplifies wound care protocols, reduces inventory, and cuts costs.

  TWC: How do you ensure proper training on products and services?
  OS: Our clinical affairs specialists and trained sales force make every effort to educate our customers about the best practices of using ENLUXTRA.

  The recent release of our interactive mobile applications is aimed at bringing common errors and treatment-associated risks to an absolute minimum. (Search for “ENLUXTRA in the iPhone or Android app stores.) In addition, dressing application guidelines, instructional videos, and troubleshooting tips are available at www.anywound.com.

  TWC: What are the future goals for you and your company?
  OS: Global expansion of our product is imminent. ENLUXTRA is already officially included into the Ministry of Health formulary in the Kingdom of Saudi Arabia. There’s a major initiative underway to have the dressing available at a large private hospital group in India.

  We are also very close to reaching the European market and fortifying our position there. With all these exciting prospects in mind, our highest goal remains the same – helping as many people around the world as we possibly can.